Reduced number of peripheral blood granulocytes in chronic myeloid leukaemia during administration of clofazimine (B 663).
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001491:Basophils / Q000187:drug effects; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D005260:Female; D006454:Hemoglobins; D006632:Histamine / Q000097:blood; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010587:Phagocytosis / Q000187:drug effects; D010619:Phenazines / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D006454:Hemoglobins; D010619:Phenazines; D006632:Histamine